[ RECIPIENT ENTITY RECORD ]

Reata Pharmaceuticals

VERIFIED NODE ID: 001722 · reata-pharmaceuticals
R TARGET NODE — CAPITAL RECIPIENT
Reata Pharmaceuticals
Company United States
Recipient Type
Company
Primary Jurisdiction
United States
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Reata Pharmaceuticals
Entity Type Company
Jurisdiction United States
Recipient Intelligence Summary

Reata Pharmaceuticals is a biopharmaceutical company dedicated to the development of novel therapies for patients with severe or life-threatening diseases with few treatment options. Headquartered in Texas, the company specializes in neurological and metabolic therapies. It was a primary recipient of institutional healthcare capital through its recent takeover.

Capital Influx Log (Transactions)
Date Type Amount
22 May 2026 EQUITY $7.3B